Adolore Biotherapeutics, Inc. | WebDisclosure

Basculer en Français

8225	Companies
111017	Keywords
52749	Articles
60935	Press releases

Headlines Articles Press releases Adolore Biotherapeutics, Inc.

Home
Companies
Adolore Biotherapeutics, Inc.

BRIEF

published on 10/02/2024 at 16:05, 1 month 5 days ago

Adolore BioTherapeutics présentera ses travaux au 18e Sommet annuel sur les thérapies contre la douleur

Adolore BioTherapeutics Traitements De La Douleur Chronique Alternatives Aux Opioïdes 18e Sommet Annuel Sur Les Thérapies Contre La Douleur Peptides Analgésiques CA8*
BRIEF

published on 10/02/2024 at 16:05, 1 month 5 days ago

Adolore BioTherapeutics to Present at 18th Annual Pain Therapeutics Summit

Adolore BioTherapeutics Chronic Pain Treatments Opioid Alternatives 18th Annual Pain Therapeutics Summit CA8* Analgesic Peptides
PRESS RELEASE

published on 10/02/2024 at 16:00, 1 month 5 days ago

Adolore BioTherapeutics to Present at 18th Annual Pain Therapeutics Summit
Adolore BioTherapeutics to present innovative opioid-free chronic pain treatments at the 18th Annual Pain Therapeutics Summit in Boston, Ma, based on cutting-edge CA8* analgesic peptides & rdHSV vectors technology

Adolore BioTherapeutics Opioid-free Chronic Pain Treatments CA8 Peptides RdHSV Vectors
BRIEF

published on 09/24/2024 at 14:25, 1 month 13 days ago

Adolore BioTherapeutics présentera son projet lors de l'événement Pitch de BioSparkVA

Adolore BioTherapeutics Douleur Chronique BioSparkVA Roy C. Levitt Thérapie Non Opioïde
BRIEF

published on 09/24/2024 at 14:25, 1 month 13 days ago

Adolore BioTherapeutics to Present at BioSparkVA Pitch Event

Adolore BioTherapeutics Chronic Pain Non-opioid Therapy BioSparkVA Roy C. Levitt
PRESS RELEASE

published on 09/24/2024 at 14:20, 1 month 13 days ago

Adolore BioTherapeutics to Present at BioSparkVA Pitch Event
Adolore BioTherapeutics to present innovative opioid-free chronic pain therapy at BioSpark Pitch Event. Programs for knee osteoarthritis & erythromelalgia in development

Adolore BioTherapeutics Chronic Pain Opioid-free Biotherapeutics Innovative Therapy
BRIEF

published on 07/30/2024 at 14:15, 3 months 8 days ago

Adolore BioTherapeutics Publishes Promising Preclinical Data on Non-Opioid Analgesic Gene Therapy

Adolore BioTherapeutics Chronic Pain Gene Therapy Osteoarthritis Non-opioid Analgesic
BRIEF

published on 07/30/2024 at 14:15, 3 months 8 days ago

Adolore BioTherapeutics publie des données précliniques prometteuses sur la thérapie génique analgésique non opioïde

Adolore BioTherapeutics Thérapie Génique La Douleur Chronique Analgésique Non Opioïde Arthrose
PRESS RELEASE

published on 07/30/2024 at 14:10, 3 months 8 days ago

Adolore BioTherapeutics Announces Publication of Compelling Preclinical Efficacy and Safety Data Supporting Adolore's Non-opioid Analgesic Gene Therapy, ADLR-1001, For Treatment of Moderate to Severe Chronic Knee Pain Due to Osteoarthritis (OA)
Adolore BioTherapeutics validates a non-opioid analgesic gene therapy for chronic pain via local delivery to sensory neurons. Preclinical study supports opioid-free treatment for chronic knee pain due to OA

Adolore BioTherapeutics Chronic Pain Gene Therapy Non-opioid Analgesic Opioid-free Treatment
BRIEF

published on 06/10/2024 at 15:20, 4 months 27 days ago

Adolore BioTherapeutics fera une présentation à la conférence virtuelle de présentation des investisseurs

Adolore BioTherapeutics Thérapie Génique Traitement De La Douleur Chronique Conférence Virtuelle De Présentation Des Investisseurs Sans Opioïdes

Accesswire

Published on 11/08/2024 at 10:00, 2 hours 7 minutes ago

BluSky Carbon CEO Presents a Case for Climate Tech Optimism
Published on 11/08/2024 at 09:00, 3 hours 7 minutes ago

Greene Tweed Awarded 'Excellence in International Trade' at the 2024 East Midlands Chamber Business Awards
Published on 11/08/2024 at 07:00, 5 hours 7 minutes ago

Polaris Renewable Energy Announces Fixed Income Meetings
Published on 11/08/2024 at 03:00, 9 hours 7 minutes ago

Alset AI Appoints Wall Street Veteran and Venture Executive as President
Published on 11/08/2024 at 01:25, 10 hours 42 minutes ago

PetroFrontier Corp. Announces Execution of Definitive Agreements for $15.1 Million Funding Arrangement

View all ACCESSWIRE

EQS Group

Published on 11/08/2024 at 11:30, 37 minutes ago

Shelly Group: Invitation to unaudited 9M 2024 earnings webcast/call on 14 November 2024
Published on 11/08/2024 at 11:12, 55 minutes ago

Original-Research: Masterflex SE (von Montega AG): Kaufen
Published on 11/08/2024 at 11:10, 56 minutes ago

Ossiam ESG Shiller Barclays CAPE® Global Sector UCITS ETF: notice of closure
Published on 11/08/2024 at 11:06, 1 hour 1 minute ago

Original-Research: Knaus Tabbert AG (von First Berlin Equity Research GmbH): Kaufen
Published on 11/08/2024 at 11:00, 1 hour 7 minutes ago

BluSky Carbon CEO Presents a Case for ClimateTech Optimism

Les Echos

Published on 11/08/2024 at 08:00, 4 hours 7 minutes ago

DAMARTEX / Droits de vote bruts et réels 31 octobre 2024
Published on 11/07/2024 at 19:00, 17 hours 7 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/07/2024 at 19:00, 17 hours 7 minutes ago

ALTAREA : DECLARATION MENSUELLE DES OPERATIONS REALISEES PAR LA SOCIETE SUR SES PROPRES TITRES OCTOBRE 2024
Published on 11/07/2024 at 19:00, 17 hours 7 minutes ago

ALTAREIT : DECLARATION MENSUELLE DES OPERATIONS REALISEES PAR LA SOCIETE SUR SES PROPRES TITRES OCTOBRE 2024
Published on 11/07/2024 at 19:00, 17 hours 7 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE